Liminatus Pharma (LIMN) Stock Chart & Stock Price History $4.94 -0.15 (-2.95%) As of 08/5/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsFDA EventsSEC FilingsTrendsBuy This Stock Liminatus Pharma Stock Price Performance The Liminatus Pharma (LIMN) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 45.23%, reflecting recent market activity. As of the latest close, Liminatus Pharma traded at $4.94 with a market cap of $128.51 million and volume of 229,670 shares. Receive LIMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-16.69%1 Month Performance-45.23% LIMN Stock Chart for Wednesday, August, 6, 2025 LIMN Chart by TradingView Liminatus Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/05/2025$5.09$4.94-2.95%$5.18$4.64229,670 shs$128.51 million08/04/2025$5.93$5.09-14.17%$6.31$4.20829,298 shs$132.39 million08/01/2025$6.27$5.93-5.42%$6.28$5.85171,387 shs$154.24 million07/31/2025$6.78$6.27-7.52%$6.84$6.10211,118 shs$163.08 million07/30/2025$6.69$6.78+1.35%$7.10$6.66316,940 shs$176.38 million07/29/2025$8.08$6.69-17.20%$8.06$6.63502,501 shs$174.01 million07/28/2025$8.71$8.08-7.23%$8.89$7.70712,493 shs$210.16 million07/25/2025$8.47$8.71+2.83%$9.38$7.90970,079 shs$226.55 million07/24/2025$6.47$8.47+30.91%$8.70$7.1311.39 million shs$220.35 million07/23/2025$5.78$6.47+11.94%$7.19$6.23762,931 shs$168.29 million Get the Latest News and Ratings for LIMN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. 07/22/2025$5.58$5.78+3.58%$7.46$5.551.10 million shs$150.34 million07/21/2025$5.42$5.58+2.95%$5.91$5.44401,894 shs$145.14 million07/18/2025$5.47$5.42-0.91%$5.78$5.25263,480 shs$140.97 million07/17/2025$5.40$5.47+1.30%$6.06$5.30379,702 shs$142.30 million07/16/2025$5.59$5.40-3.40%$5.70$5.25212,589 shs$140.45 million07/15/2025$6.33$5.59-11.69%$6.37$5.52141,707 shs$145.42 million07/14/2025$6.65$6.33-4.81%$6.90$6.00138,957 shs$164.68 million07/11/2025$7.20$6.65-7.64%$7.26$6.33180,160 shs$173 million07/10/2025$5.22$7.20+37.93%$7.45$5.82822,339 shs$187.27 million07/09/2025$6.28$5.22-16.88%$6.36$5.05369,649 shs$135.77 million07/08/2025$6.93$6.28-9.38%$8.10$5.92384,740 shs$163.37 million07/07/2025$9.02$6.93-23.17%$9.00$6.80218,015 shs$180.25 million Related Companies Stoke Therapeutics Stock Chart Day One Biopharmaceuticals Stock Chart atai Life Sciences Stock Chart KalVista Pharmaceuticals Stock Chart Tango Therapeutics Stock Chart Mind Medicine (MindMed) Stock Chart Gyre Therapeutics Stock Chart Maze Therapeutics Stock Chart ArriVent BioPharma Stock Chart Dianthus Therapeutics Stock Chart Receive LIMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LIMN) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liminatus Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liminatus Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
